These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34386604)

  • 21. Controlled attenuation parameter and alcoholic hepatic steatosis: Diagnostic accuracy and role of alcohol detoxification.
    Thiele M; Rausch V; Fluhr G; Kjærgaard M; Piecha F; Mueller J; Straub BK; Lupșor-Platon M; De-Ledinghen V; Seitz HK; Detlefsen S; Madsen B; Krag A; Mueller S
    J Hepatol; 2018 May; 68(5):1025-1032. PubMed ID: 29343427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasound-Based Attenuation Imaging for the Non-Invasive Quantification of Liver Fat - A Pilot Study on Feasibility and Inter-Observer Variability.
    Jesper D; Klett D; Schellhaas B; Pfeifer L; Leppkes M; Waldner M; Neurath MF; Strobel D
    IEEE J Transl Eng Health Med; 2020; 8():1800409. PubMed ID: 32617199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease.
    Ahn JM; Paik YH; Min SY; Cho JY; Sohn W; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Gut Liver; 2016 Mar; 10(2):295-302. PubMed ID: 26347511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis.
    Ferraioli G; Tinelli C; Lissandrin R; Zicchetti M; Dal Bello B; Filice G; Filice C
    World J Gastroenterol; 2014 Jun; 20(21):6626-31. PubMed ID: 24914387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases.
    Ni XX; Lian M; Wu HM; Li XY; Sheng L; Bao H; Miao Q; Xiao X; Guo CJ; Li H; Ma X; Hua J
    World J Gastroenterol; 2021 Jan; 27(1):80-91. PubMed ID: 33505152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered probe pressure and body position increase diagnostic accuracy for men and women in detecting hepatic steatosis using quantitative ultrasound.
    Byenfeldt M; Kihlberg J; Nasr P; Grönlund C; Lindam A; Bartholomä WC; Lundberg P; Ekstedt M
    Eur Radiol; 2024 Sep; 34(9):5989-5999. PubMed ID: 38459346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Diagnostic Value of Ultrasound-guided Attenuation Parameter (UGAP) in metabolic fatty liver disease.
    Wu H; Zeng Y; Chen F; Peng J; Chen L
    Curr Med Imaging; 2024 Feb; ():. PubMed ID: 38333977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of Ultrasound-Guided Attenuation Parameter for Grading Steatosis With Reference to MRI-PDFF in a Large Cohort.
    Imajo K; Toyoda H; Yasuda S; Suzuki Y; Sugimoto K; Kuroda H; Akita T; Tanaka J; Yasui Y; Tamaki N; Kurosaki M; Izumi N; Nakajima A; Kumada T
    Clin Gastroenterol Hepatol; 2022 Nov; 20(11):2533-2541.e7. PubMed ID: 34768008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of Controlled Attenuation Parameter for Identification and Grading of Nonalcoholic Fatty Liver Disease in Adolescents with Obesity.
    Anand A; Shalimar ; Jana M; Kandasamy D; Kumar B; Singh G; Jain V
    Indian J Pediatr; 2022 Jan; 89(1):52-58. PubMed ID: 34324132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A meta-analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver disease.
    Gu Q; Cen L; Lai J; Zhang Z; Pan J; Zhao F; Yu C; Li Y; Chen C; Chen W; Shen Z
    Eur J Clin Invest; 2021 Feb; 51(2):e13446. PubMed ID: 33128454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatorenal Index by B-Mode Ratio Versus Imaging and Fatty Liver Index to Diagnose Steatosis in Alcohol-Related and Nonalcoholic Fatty Liver Disease.
    Kjaergaard M; Lindvig KP; Hansen CD; Detlefsen S; Krag A; Thiele M
    J Ultrasound Med; 2023 Feb; 42(2):487-496. PubMed ID: 35475550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Head-to-head comparison of three different US-based quantitative parameters for hepatic steatosis assessment: a prospective study.
    Zhou Y; Nie M; Zhou H; Mao F; Zhao L; Ding J; Jing X
    Abdom Radiol (NY); 2024 Jul; 49(7):2262-2271. PubMed ID: 38740581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reproducibility of ultrasound-guided attenuation parameter (UGAP) to the noninvasive evaluation of hepatic steatosis.
    Zhao Y; Jia M; Zhang C; Feng X; Chen J; Li Q; Zhang Y; Xu W; Dong Y; Jiang Y; Liu Y; Huang P
    Sci Rep; 2022 Feb; 12(1):2876. PubMed ID: 35190618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis.
    Petroff D; Blank V; Newsome PN; Shalimar ; Voican CS; Thiele M; de Lédinghen V; Baumeler S; Chan WK; Perlemuter G; Cardoso AC; Aggarwal S; Sasso M; Eddowes PJ; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Cobbold JF; Naveau S; Lupsor-Platon M; Mueller S; Krag A; Irles-Depe M; Semela D; Wong GL; Wong VW; Villela-Nogueira CA; Garg H; Chazouillères O; Wiegand J; Karlas T
    Lancet Gastroenterol Hepatol; 2021 Mar; 6(3):185-198. PubMed ID: 33460567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.
    de Lédinghen V; Vergniol J; Foucher J; Merrouche W; le Bail B
    Liver Int; 2012 Jul; 32(6):911-8. PubMed ID: 22672642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel quantitative assessment system of liver steatosis using a newly developed attenuation measurement method.
    Tamaki N; Koizumi Y; Hirooka M; Yada N; Takada H; Nakashima O; Kudo M; Hiasa Y; Izumi N
    Hepatol Res; 2018 Sep; 48(10):821-828. PubMed ID: 29679473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic Accuracy of Controlled Attenuation Parameter for Detecting Hepatic Steatosis in Patients with Chronic Liver Disease.
    Andrade P; Rodrigues S; Rodrigues-Pinto E; Gaspar R; Lopes J; Lopes S; Macedo G
    GE Port J Gastroenterol; 2017 Jul; 24(4):161-168. PubMed ID: 29255745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of B-mode ultrasound-based attenuation for the diagnosis of hepatic steatosis: a systematic review/meta-analysis.
    Hirooka M; Koizumi Y; Sunago K; Nakamura Y; Hirooka K; Watanabe T; Yoshida O; Tokumoto Y; Abe M; Hiasa Y
    J Med Ultrason (2001); 2022 Apr; 49(2):199-210. PubMed ID: 35239088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease.
    de Lédinghen V; Wong GL; Vergniol J; Chan HL; Hiriart JB; Chan AW; Chermak F; Choi PC; Foucher J; Chan CK; Merrouche W; Chim AM; Le Bail B; Wong VW
    J Gastroenterol Hepatol; 2016 Apr; 31(4):848-55. PubMed ID: 26514665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic accuracy of controlled attenuation parameter measured by transient elastography for the non-invasive assessment of liver steatosis: a prospective study.
    Lupșor-Platon M; Feier D; Stefănescu H; Tamas A; Botan E; Sparchez Z; Maniu A; Badea R
    J Gastrointestin Liver Dis; 2015 Mar; 24(1):35-42. PubMed ID: 25822432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.